← All Investors
GMO ETF TRUST
GMOV
Holders
3
Combined Value
$4.4M
Combined Shares
157,679
Current Price
$29.75
52W High
$30.57
vs 52W High
−2.7%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Jeremy Grantham - GMO | $3.4M | 0.01% | ~$27.76 | +7.2% | Bought Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $660K | 0.00% | ~$28.10 | +5.9% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $327K | 0.00% | ~$28.10 | +5.9% | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Jeremy Grantham - GMO | BUY | +$1.5M | ~$28.10 |
| Q1 2026 | Cliff Asness - AQR Capital | NEW BUY | +$660K | ~$28.10 |
| Q1 2026 | Ken Griffin - Citadel Advisors | NEW BUY | +$327K | ~$28.10 |
| Q4 2025 | Jeremy Grantham - GMO | NEW BUY | +$1.9M | ~$27.49 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$794K | ~$26.42 |
| Q3 2025 | Ken Griffin - Citadel Advisors | BUY | +$552K | ~$26.42 |
| Q2 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$231K | ~$25.27 |
| Q1 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$732K | ~$24.45 |
| Q4 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$732K | ~$24.45 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 3 | 157,679 | +131.3% | $4.4M | $28.10 |
| Q4 2025 | 1 | 68,184 | +126.7% | $1.9M | $27.49 |
| Q3 2025 | 1 | 30,075 | +228.3% | $794K | $26.42 |
| Q2 2025 | 1 | 9,162 | −69.4% | $231K | $25.27 |
| Q4 2024 | 1 | 29,956 | — | $732K | $24.45 |